Latest Market News

Alice Queen Limited (AQX) has been suspended from ASX quotation due to its failure to adequately respond to regulatory queries, raising questions about its compliance status and future trading prospects.

Osteopore Limited has inked an exclusive collaboration with Majeton to commercialise its cutting-edge 3D-printed bioresorbable implants across China, Hong Kong, and Macau, unlocking significant growth potential in the region.

NOVONIX has delayed the start of mass production of battery-grade synthetic graphite anode material for Panasonic Energy to the second half of 2027, while maintaining its 2026 target for industrial-grade graphite production.

ION Video Ltd’s recent General Meeting saw overwhelming shareholder approval for crucial resolutions, including a securities consolidation and advisor options ratification.

Eagle Mountain Mining has issued nearly 120 million new shares and 40 million options, raising just over $1 million, but a significant shortfall remains to be placed. The company aims to secure additional funding to advance its Arizona copper-gold projects.

Northern Minerals reports encouraging preliminary metallurgical results from blending the Dazzler deposit with Wolverine ore, potentially expanding feed supply and optimising the Browns Range Heavy Rare Earths Project.

Navigator Global Investments reported steady ownership-adjusted assets under management of USD29 billion for the December 2025 quarter, buoyed by strong hedge fund performance and resilient private markets growth despite the Bardin Hill sale.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

APC Minerals Limited has raised $264,000 through a discounted top-up placement of 66 million shares, enhancing its financial capacity to pursue new and existing projects.

Terra Critical Minerals has completed the acquisition of the True American Tungsten Project in Nevada, positioning itself to capitalise on soaring tungsten prices and supply constraints. The company plans extensive exploration in 2026 to validate and expand this historically high-grade asset.

Vitasora Health has completed an A$11 million capital raise, including a cornerstone investment, bolstering its balance sheet to support ambitious growth in the US healthcare market. The company targets cash flow breakeven by the end of FY2026 amid expanding patient programs and new partnerships.

Bass Oil reported steady December production with a notable gas sales agreement for the Vanessa field, signaling a strategic shift towards gas commercialization.